The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...

The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that ...

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

Supreme Court set to consider cert. petition on generic drug use of “skinny labels” to avoid infringing method of use patents. Court expected to consider cert. petition during court conference on May ...

The Skinny Labels, Big Savings Act was introduced on January 9 in an effort to provide “a statutory safe harbor from patent ...

Brian Coggio, Karrie Wheatley Ph.D. Courts may infer the requisite specific intent from statements that appear in the generic manufacturer’s label. “When proof of intent depends on the label ...

The U.S. Court of Appeals for the Federal Circuit sided with a jury’s 2017 finding that Teva swayed doctors away from using GlaxoSmithKline’s drug Coreg (carvedilol) for a use of its drug that was ...

CINCINNATI (CN) - A woman who developed a neurological disorder while taking a generic acid reflux drug can pursue her failure-to-warn claims in state court, the 6th Circuit ruled. Eleanor Fulgenzi ...

The vast majority of patients who initiated imatinib therapy for gastrointestinal stromal tumors (GISTs) received a generic drug that did not have FDA approval for that indication, a large ...

After a ‘skinny label’ was used to market a generic version of a pricey brand-name medicine, more consumers gained access to the lower-cost copycat drug and saved on out-of-pockets cost, a new study ...